Re: omiting the primary Ab for IHC control,
<< Previous Message | Next Message >>
| From: | Tony Henwood <henwood@mail.one.net.au> (by way of histonet) |
| To: | histonet <histonet@magicnet.net> |
| Reply-To: | |
| Content-Type: | text/plain; charset="us-ascii" |
It is a good idea to include a negative control with each case. Often
when a panel of antibodies (eg S100, keratin and LCAg) are used the
"negative" control is superfluous since one hopes that the tumour
will be negative for one of the panel antibodies used.
Tony Henwood
www2.one.net.au/~henwood
<< Previous Message | Next Message >>